What We're Reading: Page 24
Industry reads hand-picked by our editors
May 29, 2025
-
Axios
China’s biotech boom leaves U.S. playing catch-up
-
The Washington Post
CDC blindsided as RFK Jr. changes vaccine recommendations
-
The Atlantic
The Perilous Spread of the Wellness Craze
May 28, 2025
-
Bloomberg
RFK Jr.’s Vow to End TV Drug Ads Threatens Broadcast Networks
-
MarketWatch
Vivek Ramaswamy’s firm wants to buy biotech companies to bet on bitcoin
-
Politico
RFK Jr. threatens to bar government scientists from publishing in leading medical journals
-
PharmaVoice
What’s next for Trump’s ‘most favored nation’ policy?
May 27, 2025
May 22, 2025
-
Reuters
Prices for new US drugs doubled in 4 years as focus on rare disease grows
-
The Wall Street Journal
What’s Inside RFK Jr.’s MAHA Report
-
KFF Health News
Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
-
Nature
#OpenToWork: how laid-off US scientists are coping with shattered careers
May 21, 2025
May 20, 2025
-
The Wall Street Journal
The Next Frontier to Treat Cancer: Electricity
-
The Financial Times
More than 120 countries back treaty to share vaccines in pandemics
-
Nature
AI tool flags people at high risk of postpartum depression
May 19, 2025
-
Bloomberg
Zepbound Craze Boosts $80 Billion Lilly Endowment to Largest in US
-
Fierce Biotech
Boehringer’s phase 3 lung data get muted response from analysts
-
MIT Technology Review
The first US hub for experimental medical treatments is coming
Previous
